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Epithelial–mesenchymal transitionMicroRNAs (miRNAs) play a critical role in the development of cancers. However, the role of miRNAs
in glioma is still poorly understood. In this study, we demonstrate that microRNA-10a (miR-10a)
promotes cell migration and invasion by negatively regulating the expression of Eph tyrosine kinase
receptor A8 (EphA8). Ectopic expression of EphA8 counteracts the promotion of migration and
invasion induced by miR-10a. We further demonstrate that miR-10a and EphA8 regulate epithe-
lial–mesenchymal transition (EMT) to affect cell migration and invasion. Collectively, we unveil a
branch of the miR-10a/EphA8 pathway that regulates the progression of glioma.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction now, many miRNAs have been reported to regulate glioma devel-Malignant gliomas are the most common primary tumors of the
central nervous system. They are characterized by high invasion,
migration and proliferation abilities. Grade IV astrocy-tomas are
known as glioblastoma multiforme (GBM). Despite aggressive sur-
gery combined with radiation, chemotherapy, and biological ther-
apy, the median survival is only 12–15 months for patients with
GBM [1]. Many factors inﬂuence the effectiveness of glioma thera-
pies, including rapid and invasive tumor growth. Hence, there is a
recognized need for new approaches based on increased under-
standing of the biological and molecular nature of these tumors.
MicroRNAs (miRNAs) are endogenous, small, non-coding RNAs
that regulate gene expression by antisense complementarity to
speciﬁc mRNA. MiRNAs have been demonstrated to play critical
roles in the biologic processes such as cell migration, invasion, pro-
liferation, apoptosis, stress resistance, and cell identity [2–5]. Untilopment, including miR-335 [6], miR-218 [7], miR-15b, miR-152
[8], miR-92b [9], miR-145 [10], and miR-124 [11], et al. However,
the effect of miR-10a on glioma has not been reported. Our previ-
ous studies have demonstrated that miR-10a was involved in
metastatic process in hepatoma cells [12]. Thus, we investigated
whether miR-10a also contributed to the metastatic behavior of
glioma cells.
Ephrin receptors comprise the largest known family of receptor
tyrosine kinases (RTKs), which interact with their ligands, ephrins.
Recently, compelling evidence suggested that expression of ephrin
ligands and receptors is often reduced in advanced-stage tumors
and regulates tumor growth, metastasis and angiogenesis by alter-
ing cell proliferation, motility, invasion and migration [13]. Recent
genetic studies suggested that EphA8was involved in regulating cell
adhesion and apoptosis [14,15]. However, reports about the rela-
tionship of EphA8 and cell migration and invasion were still few.
The process of metastasis consists of a series of steps. Among
them, the epithelial–mesenchymal transition (EMT) is commonly
characterized by the suppression of the cell–cell adhesion receptor
E-cadherin and endows cells with more motile, invasive properties
[16]. Accumulating evidence suggested that many miRNAs were
involved in EMT [17,18]. Our previous studies have also suggested
that miR-10a could promote cell migration and invasion by
regulating EMT process in hepatoma [12].
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and invasion of the human glioma cell lines U251 and U87. We
identiﬁed EphA8 as a direct target of miR-10a. Furthermore, we
found that miR-10a and EphA8 regulated the EMT process to inﬂu-
ence the cell migration and invasion. Together, these data con-
tribute to the characterization of the molecular mechanisms of
glioma progression.2. Materials and methods
2.1. Cell culture, transfection and RNA extraction
Human glioma cell lines, including U251, U87, A172, U118 and
LN18were cultured at 37 Cwith 5% CO2 in DMEM (Gibco, Gaithers-
burg, USA) supplemented with 10% fetal bovine serum (FBS).
Transient transfection was performed using the Lipofectamine
2000 reagent (Invitrogen, Carlsbad, USA). Total RNA was extracted
using the Trizol reagent (Invitrogen), and miRNAs were obtained
using the mirVana miRNA isolation kit (Ambion, Austin, USA).
2.2. Clinical glioma samples
Human glioma samples were collected from the neurosurgery
department of Huan Hu Hospital of Tianjin in China from 20 adult
patients, freshly resected during surgery. All samples were imme-
diately sectioned from the resected glioma tissues, frozen in liquid
nitrogen and stored at 80 C. There were 8 low-grade (3 from
WHO grades I and 5 from WHO grades II) and 12 high-grade
tumors (5 from WHO grades III and 7 from WHO grades IV). None
of patients had received chemotherapy, immunotherapy and radio-
therapy prior to specimen collection. All patients gave written
informed consent according to a study protocol that was approved
by Tissue Committee and Research Ethics Board of Huan Hu Hospi-
tal of Tianjin.
2.3. Vector constructions
The vector constructions used in this study was shown in Sup-
plementary materials and methods.
2.4. Bioinformatics analysis
The target gene information of miR-10a was analyzed using
miRanda, Targetscan, and PicTar.
2.5. EGFP reporter assay
Glioma cells were transiently cotransfected with EGFP reporter
plasmid and pcDNA3-pri-10a, pcDNA3, ASO-miR-10a and ASO-NC,
respectively. The RFP expression vector, pDsRed2-N1, was used as
the internal control. Intensities of EGFP and RFP ﬂuorescence were
detected with an F-4500 ﬂuorescence spectrophotometer (Hitachi,
Tokyo, Japan).
2.6. Quantitative real-time PCR (qRT-PCR) and Western blot analysis
Target genes and controls were analyzed by qRT-PCR using
SYBR Premix Ex TaqTM (TaKaRa, Dalian, China).
Cell lysates were separated on 8% SDS denatured polyacry-
lamide gel, transferred to nitrocellulose membranes and blocked
in phosphate-buffered saline/Tween-20 containing 5% non-fat
milk. The membranes were incubated with antibodies.
Details and antibodies were under Supplementary materials
and methods.2.7. Migration and invasion assays
For the transwell migration assay, 5  104 U251 or U87 cells
were placed in the upper chamber of each insert (Corning, Cam-
bridge, USA). For the invasion assay, 5  104 cells were placed on
the upper chamber of each insert coated with 40 ll matrigel (Clon-
tech, Mountain View, CA), which was diluted to 2 lg/ll with
DMEM medium. Medium supplemented with 20% FBS (600 ll)
was added to the lower chambers. After several hours of incuba-
tion (24 h for U251 and U87 in the migration assays; 48 h for
U251 and U87 in the invasion assays), the upper surface of the
membrane was wiped with a cotton tip and cells attached to the
lower surface were stained for 20 min with crystal violet. Cells in
ﬁve random ﬁelds of view at 100 magniﬁcation were counted
and expressed as the average number of cells per ﬁeld of view.
2.8. Statistical analysis
Data are presented as the mean ± S.D. Statistical analyses were
performed using a paired t-test to compare data. A P-value less
than 0.05 were considered statistically signiﬁcant.
3. Results
3.1. Upregulation of miR-10a in human glioma tissues and cell lines
To determine whether miR-10a was involved in the tumorige-
nesis or development of glioma, we ﬁrstly examined the expres-
sion of miR-10a in clinical tissues and glioma cell lines. Among
20 paired clinical specimens, miR-10a was signiﬁcantly up-
regulated in glioma tissues compared to the adjacent non-cancer-
ous tissues. Meanwhile, the miR-10a expression was higher in
grade III and IV gliomas compared to grade I and II tumors
(Fig. 1A). qRT-PCR was performed on a panel of 5 human glioma
cell lines and primary normal human astrocytes (NHA). Remark-
able up-regulation of miR-10a could also be observed in glioma cell
lines than that of NHA (Fig. 1B). These results suggested that miR-
10a could be closely related to human glioma and high level of
miR-10a might be related to glioma oncogenesis and progression.
3.2. miR-10a promotes glioma cell migration and invasion in vitro
To determine whether miR-10a had an effect on the malignant
phenotype of glioma cells, we constructed a miR-10a expression
plasmid (pcDNA3-pri-10a, pri-miR-10a) and validated the efﬁcien-
cy of pri-miR-10a and the antisense oligonucleotide of miR-10a
(ASO-miR-10a) (Fig. S1). U251 and U87 cells were then transfected
with them or their respective controls to explore their effects on
the cancer cells. Since invasiveness is one of the pathophysiological
features of glioma, we asked whether miR-10a over-expression
was associated with the invasiveness of gliomas. Transwell migra-
tion and invasion assays showed that the migration (Fig. 2A) or
invasion (Fig. 2B) capacities of U251 cells transfected with pri-
miR-10a was increased by approximately 2.7- or 1.7-fold. ASO-
miR-10a reduced these capacities by almost 76% or 69% when com-
pared to the controls. The similar results were observed in U87
cells (Fig. 2C and D). These ﬁndings indicated that miR-10a pro-
moted both the migration and invasion of glioma cells.
3.3. miR-10a targets the 30-UTR of EphA8 transcripts and negatively
regulates its expression
miRNAs inﬂuence cell behavior by regulating the expression of
target genes. To explore the molecular mechanism through which
miR-10a exerts its function in glioma cells, we predicted and iden-
Fig. 1. miR-10a was up-regulated in human glioma tissues and cell lines. (A) Real-time PCR analysis of miR-10a expression in glioma tissues from different grades and
adjacent non-cancerous tissues. Box-plot lines represent medians and interquartile ranges of the normalized threshold values. (B) Real-time PCR analysis of miR-10a
expression in several glioma cell lines. U6 was used as loading control. Differences between groups were assessed by one-way ANOVA with the LSD method, ⁄P < 0.05,
⁄⁄P < 0.01.
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MiRanda, Targetscan and PicTar were used to predict the potential
target gene(s). Considering the associated genes that could account
for cell migration or invasion, Eph tyrosine kinase receptor 8,
EphA8, was chosen for further study.
Base-pairing complementation revealed that the 30 untranslat-
ed region (UTR) of EphA8 contains a putative binding region of
miR-10a (Fig. 3A). To determine whether EphA8 is a direct target
of miR-10a, a series of 30UTR fragments-including full length 30UTR,
binding site 1 and binding site 2 were constructed and inserted
into the region immediately downstream of the luciferase reporter
gene. The pri-miR-10a or ASO-miR-10a constructs were then
cotransfected with the EGFP reporter vector into U251 cells. Inter-
estingly, EGFP intensities were reduced by almost 73% by miR-10a
when the full-length wild-type 30-UTR of EphA8 was present
(Fig. 3B), and when miR-10a expression was blocked, the EGFP
intensities were enhanced by approximately 2.2-fold (Fig. 3B).
The repressive effect on EGFP activity was abrogated by a mutation
in the seed region of the EphA8-30UTR 1 fragment and partially
attenuated by a mutation in the seed region of EphA8-30UTR 2 frag-
ment (Fig. 3C and D). Similar ﬁndings were observed in U87 cells
(Fig. S2). These results indicated that these sites were necessary
for miR-10a binding.
To determine if miR-10a suppressed endogenous EphA8
expression, qRT-PCR and Western blot analysis was used anddemonstrated that over-expression of miR-10a dramatically sup-
pressed the endogenous mRNA and protein levels of EphA8 by
64% and 45%, respectively, whereas the inhibition of miR-10a
increased the expression of EphA48 by 2.2- and 1.8-fold in U251
cells (Fig. 3E and F). The similar results were detected in U87 cells
(Fig. S2).
3.4. EphA8 is often down-regulated in glioma and suppresses glioma
cell migration and invasion
We have identiﬁed EphA8 as a direct target of miR-10a. To bet-
ter understand the potential role of EphA8 in miR-10a-mediated
migration and invasion, the mRNA level of EphA8 was also mea-
sured in 20 paired clinical specimens. The level of EphA8 was sig-
niﬁcantly down-regulated in glioma tissues when compared with
adjacent non-cancerous tissues (Fig. 4A), and was strongly corre-
lated with the up-regulation of miR-10a (Fig. 4B). Furthermore,
the mRNA expression of EphA8 was also analyzed in glioma cells
(Fig. 4C). These data suggested that EphA8 expression was
reduced in glioma and was inversely correlated with miR-10a
expression.
In order to explore the biological functions of EphA8, we con-
structed the pSilencer/siR-EphA8 plasmid to knockdown endoge-
nous EphA8 expression and Western blot analysis showed that
EphA8 protein expression level was reduced by almost 75% or
Fig. 2. miR-10a promotes glioma cell migration and invasion in vitro. (A) Transwell migration assay of human glioma cell line U251 cotransfected with either miR-10a or
ASO-miR-10a and their control vectors. (B) Transwell invasion assay of U251 cells. (C and D) Transwell migration and invasion assays of human glioma cell line U87.
Representative images are shown behind. Cells in ﬁve random ﬁelds of view at 100 magniﬁcation were counted and expressed as the average number of cells per ﬁeld of
view, ⁄⁄P < 0.01.
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endogenous EphA8 resulted in a signiﬁcant increase in cell migra-
tion by 3.1- and 3.5-fold (Fig. 5B), and an increase in invasion by
2.6- and 2.8-fold, respectively (Fig. 5C). These results suggested
EphA8 could suppress cell migration and invasion of glioma cells.
3.5. Ectopic expression of EphA8 restores the inﬂuence of miR-10a in
cell migration and invasion
The data above indicated that miR-10a could negatively regu-
late the expression of EphA8 both at the mRNA and protein levels
by directly binding to its 30-UTR and knockdown of EphA8 could
mimic the miR-10a over-expression. To further conﬁrm that miR-
10a promoted the migration and invasion of glioma cells by
regulating EphA8 directly, we perfumed a rescue experiment.
U251 cells were cotransfected with miR-10a and pA3M1-EphA8,
which encoded the entire EphA8 coding sequence but lacked the
30-UTR. Western blot analysis was used to validate the EphA8
expression in the rescue experiment (Fig. 6A). As expected, the
restoration of EphA8 inhibited the miR-10a-promoted migration
and invasion (Fig. 6B). Similar data was detected in U87 cells
(Fig. 6C). Taken together, these ﬁndings suggested that miR-10a
promoted glioma cell migration and invasion by directly targeting
EphA8.
3.6. miR-10a and EphA8 affect glioma cell migration and invasion by
regulating of the EMT process
The above observations suggested that miR-10a could promote
glioma cell migration and invasion and exerted its function by
directly regulating EphA8, we further investigated the mechanism
by which miR-10a and EphA8 regulate the cell malignantphenotype. We noticed a striking change in cellular shape due to
the miR-10a inhibition or EphA8 over-expression, an initial
ﬁbroblast-like morphology was observed to switch to the cobble-
stone-like appearance of epithelial cells. To determine whether
the typical molecular alternations of EMT occurred, the protein
levels of epithelial (E-Cadherin) and mesenchymal (Vimentin and
ICAM-1) markers were measured. As shown in Fig. 7A, EphA8
expression was increased by 1.5- or 2.8-fold after transfection of
ASO-miR-10a or pA3M1-EphA8 plasmid in U251 cells. E-Cadherin
protein expressionwas up-regulated by 1.1-fold, whereas Vimentin
and ICAM-1 were down-regulated by 62% and 78% respectively
whenmiR-10awas blocked (Fig. 7B) in U251 cells. In addition, simi-
lar results were observedwhen EphA8was over-expressed (Fig. 7C).
Furthermore, similar observations were obtained in U87 cells
(Fig. S3). The above ﬁndings suggested that miR-10a and its target
gene, EphA8, could affect glioma cell migration and invasion by
regulating of EMT process.
Above all, our ﬁndings indicate that miR-10a promotes, where-
as EphA8 suppresses glioma cell migration and invasion in vitro.
miR-10a exerts its function by directly repressing EphA8. miR-
10a and EphA8 affect glioma cell malignant phenotype by regulat-
ing of the EMT process. These observations proved a new miR-
10a/EphA8 regulation pathway of cell migration and invasion in
glioma.
4. Discussion
Diffusely inﬁltrating gliomas are one of the most devastating
cancers because they often show locally aggressive behavior and
cannot be cured by existing therapies [19]. Gliomas develop as a
result of genetic alterations that accumulate throughout tumor
progression [20]. Therefore, the elucidation of these molecular
Fig. 3. miR-10a targets the 30-UTR of EphA8 and down-regulates its expression. (A) The sequence of the predicted miR-10a binding site and the EphA8 30-UTR segments
containing the wild-type or mutant binding site are shown. The protein binding sequences for miR-10a within the EphA8 30-UTR of human, chimpanzee, mouse, rat and
guinea pig are also shown. Seed sequences are highlighted. (B) Relative EGFP activity was analyzed after the wild-type full-length EphA8-30UTR plasmid was cotransfected
with miR-10a or ASO-miR-10a in U251 cells. (C) EGFP intensity was analyzed after the mutant 30-UTR-1 reporter plasmids was cotransfected with miR-10a or ASO-miR-10a.
(D) EGFP intensity was analyzed after the mutant 30-UTR-2 reporter plasmids was cotransfected with miR-10a or ASO-miR-10a. The histogram shows the mean ± S.D. of the
normalized EGFP intensity. (E) Real-time PCR analysis was used to detect the mRNA level of EphA8 in transiently transfected U251 cells. Normalization was performed using
b-actin. (F) Western blot analysis was used to detect the protein level of EphA8 in transiently transfected U251 cells. Normalization was performed using GAPDH, ⁄P < 0.05,
⁄⁄P < 0.01.
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tion and invasion is crucial for a better prediction of glioma
patients outcome and response to therapies [21]. Recent studies
have shown that miRNAs play a fundamental role in the migration
and invasion of glioma. For example, miR-204 inhibits glioma cell
migration and invasion by negatively regulating ezrin geneexpression [22]. MiR-18a regulates the proliferation, migration
and invasion of human glioblastoma cell by targeting neogenin
[23]. MiR-10a, which was studied in many research was involved
in regulating the migration and invasion of many kinds of cancers,
such as cervical and gastric cancers [24,25]. Our previous studies
also suggested that miR-10a could promote cell migration and
Fig. 4. EphA8 is often down-regulated in glioma tissues and cell lines. (A) Real-time PCR was used to detect the mRNA levels of EphA8 in clinical specimens. Box-plot lines
represent medians and interquartile ranges of the normalized threshold values. The EphA8 abundance was normalized to b-actin. (B) Correlation between expression level of
EphA8 and that of miR-10a in 20 matched tissues. Linear regression coefﬁcient and statistical signiﬁcance is indicated. (C) Real-time PCR was used to detect the mRNA levels
of EphA8 in glioma cell lines, ⁄⁄P < 0.01.
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effect of miR-10a on glioma has not been reported.
In this study, miR-10a, a new regulator of glioma, was shown to
promote migration and invasion of U251 and U87 glioma cells. To
further explore the mechanism by which miR-10a exerts its func-
tion, we used bioinformatics analysis to predict and ﬁnally identi-
ﬁed EphA8 as the direct target of miR-10a. This conclusion is based
on several experimental evidences. First, miR-10a signiﬁcantly
decreases the expression of EphA8 both at the mRNA and protein
levels in glioma cells. Second, the EGFP reporter assay showed that
the ﬂuorescence intensity of EGFP-EphA8-30UTR was speciﬁcally
responsive to miR-10a over-expression, however, mutation of the
miR-10a binding site abolished the effect of miR-10a on theregulation of EGFP ﬂuorescence intensity. Third, EphA8 expression
is down-regulated in HCC tissues, and this down-regulation is
strongly correlated with the up-regulation of miR-10a. Fourth,
knockdown of EphA8 phenocopies the effect of miR-10a
expression, whereas restoration of EphA8 counteracts the function
of miR-10a. These results indicate that miR-10a targets EphA8 and
down-regulates its expression in glioma.
Ephrin receptors comprise the largest known family of receptor
tyrosine kinases (RTKs), with 16 Eph receptors and 9 ephrin ligands
[27–29]. Eph receptors and ligands are divided into either A-class or
B-class, and were initially implicated in cell positioning and migra-
tion during development, particularly of the nervous system. Until
now, reports have suggested that many Eph receptors are involved
Fig. 5. EphA8 suppresses the migration and invasion of glioma cells in vitro. (A) Western blot analysis of EphA8 protein level in U251 and U87 cells transfected with pSilencer/
shR-EphA8 or pSilencer plasmids. (B) Transwell migration analysis of glioma cells when EphA8 was inhibited. (C) Transwell invasion analysis of glioma cells when EphA8 was
inhibited. Cells in ﬁve random ﬁelds of view at 100 magniﬁcation were counted and expressed as the average number of cells per ﬁeld of view, ⁄⁄P < 0.01.
762 Y. Yan et al. / FEBS Letters 589 (2015) 756–765in regulating proliferation, migration, invasion and adhesion of
glioma cells [30–34]. In this study, transwell assay demonstrated
that knockdown of EphA8 could promote cell migration and
invasion of glioma which was in accordance with miR-10a
over-expression. Ectopic expression of EphA8 without the 30UTR
rescued the promotion of migration and invasion in U251 and
U87 cells caused by miR-10a.
As mentioned above, EMT is a process in which epithelial cells
lose or modify their apical–basal polarity during embryonic
development and tumor metastasis [35,36]. Our previous studyhas suggested that miR-10a could affect cell malignant behavior
via regulating the EMT process [12]. Barrios et al. [37] have
indicated that one of the RTKs family members, EphA4, regulates
the mesenchymal-to-epithelial transition (MET) of the paraxial
mesoderm during somite morphogenesis. We speculated that
miR-10a and EphA8 played roles in the EMT process in glioma.
We examined the expression of the epithelial marker E-cadherin
and the mesenchymal markers Vimentin and ICAM-1. Because
miR-10a expression was increased whereas EphA8 was decreased
in cancer tissues and glioma cells, we blocked miR-10a expression
Fig. 6. Ectopic expression of EphA8 restores the inﬂuence of miR-10a in cell migration and invasion. (A) Western blot analysis of EphA8 expression in U251 and U87 cells with
or without EphA8 restoration. (B) Restoration of EphA8 inhibits miR-10a-promoted glioma cell migration and invasion in U251 cells. (C) Restoration of EphA8 inhibits miR-
10a-promoted glioma cell migration and invasion in U87 cells. Cells in ﬁve random ﬁelds of view at 100magniﬁcation were counted and expressed as the average number of
cells per ﬁeld of view, ⁄⁄P < 0.01.
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related molecular markers. As expected, inhibition of miR-10a or
over-expression of EphA8 suppressed the EMT phenotype. In other
words, miR-10a can increase, whereas EphA8 can suppress
cell migration and invasion of glioma by mediating the EMT
process.In summary, we discovered that miR-10a can promote cell
migration and invasion of glioma and exerts its function by directly
targeting EphA8, thereby regulating EMT process. Our research
thus provides a new insight into the mechanism of the patho-
genesis of glioma and suggests miR-10a and EphA8 play important
roles in progression of glioma.
Fig. 7. miR-10a and EphA8 affect glioma cell migration and invasion via regulating of the EMT process. (A) Western blot analysis of EphA8 protein level when miR-10a
expression was inhibited or EphA8 was over-expressed in U251 cells. (B) The protein expression levels of E-Cadherin, Vimentin and ICAM-1 when miR-10a was inhibited in
U251 cells. (C) The protein expression levels of epithelial and mesenchymal markers mentioned above when EphA8 was over-expressed in U251 cells, ⁄⁄P < 0.01.
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